Greulich, H., Chen, T.-H., Feng, W., Jänne, P. A., Alvarez, J. V., Zappaterra, M., … Meyerson, M. (2024). Correction: Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants. PLoS Med, 21(9), e1004470. https://doi.org/10.1371/journal.pmed.1004470

Greulich, Heidi, Tzu-Hsiu Chen, Whei Feng, Pasi A. Jänne, James V. Alvarez, Mauro Zappaterra, Sara E. Bulmer, et al. “Correction: Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants.” PLoS Med 21, no. 9 (September 2024): e1004470. https://doi.org/10.1371/journal.pmed.1004470.

Greulich H, Chen T-H, Feng W, Jänne PA, Alvarez JV, Zappaterra M, et al. Correction: Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants. PLoS Med. 2024 Sep;21(9):e1004470.

Greulich, Heidi, et al. “Correction: Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants.” PLoS Med, vol. 21, no. 9, Sept. 2024, p. e1004470. Pubmed, doi:10.1371/journal.pmed.1004470.

Greulich H, Chen T-H, Feng W, Jänne PA, Alvarez JV, Zappaterra M, Bulmer SE, Frank DA, Hahn WC, Sellers WR, Meyerson M. Correction: Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants. PLoS Med. 2024 Sep;21(9):e1004470.